Boehringer Ingelheim Korea is a Korean subsidiary of the Boehringer Ingleheim group. It was founded in 1976 in Korea, with 270 employees. It has been committed to supplying and marketing innovative products in Prescription Medicines, Consumer Health Care, and Animal Health.

TRAJENTA®, TRAJENTA DUO®, JARDIANCE®, JARDIANCE DUO® (Type 2 Diabetes), TWYNSTA®, MICARDIS® (Hypertension), GIOTRIF® (Lung Cancer), SPIRIVA® (Asthma, COPD), VAHELVA® (COPD), PRADAXA® (Stroke Prevention in Atrial Fibrillation)

JARDIANCE